{21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Luizza... — RxCUI 2712092
RxNorm drug concept · Brand name pack
RxCUI 2712092
Brand name pack · BPCK
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2712092
Official name{21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Luizza 1.5/30 21 Day]
Concept typeBrand name pack (BPCK)
RxNorm statusCurrent RxNorm concept
Also known asLuizza 1.5/30 21 Day Pack
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Norethindrone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the product. Most norethindrone tablets — including brands like Camila, Errin, Emzahh, and Affodel — are progestin-only birth control pills taken daily to prevent pre...
- Regular combination birth control pills contain two hormones — estrogen and progestin. Norethindrone is a progestin-only pill, sometimes called the 'mini-pill.' Because it has no e...
- How is this different from regular birth control pills?
- The most common thing people notice is irregular bleeding — spotting between periods, or changes in your cycle. Headache, breast tenderness, nausea, and dizziness are also reported...
🕸️ Concept Web — How {21 (ethinyl estradiol 0.03 MG / norethindrone a... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
{21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Luizza 1.5/30 21 Day]
RxCUI 2712092 Brand name pack · BPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Ethinyl estradiol
4124IN -
Norethindrone
7514IN -
Ethinyl estradiol / norethindrone
384410MIN -
Norethindrone acetate
31983PIN
-
Ethinyl estradiol
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ethinyl estradiol / norethindrone Oral Tablet
372105SCDF -
Ethinyl estradiol / norethindrone acetate Oral Tablet
2648046SCDFP -
Ethinyl estradiol / norethindrone Oral Product
1157354SCDG -
Ethinyl estradiol / norethindrone Pill
1157355SCDG -
Ethinyl estradiol / norethindrone acetate Oral Product
2661574SCDGP -
Ethinyl estradiol / norethindrone acetate Pill
2661136SCDGP -
Pack
746839DF -
Oral Product
1151131DFG - +1 more in this family
-
Ethinyl estradiol / norethindrone Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet
1359022SCD -
Ethinyl estradiol 0.03 MG
315897SCDC -
Norethindrone acetate 1.5 MG
1359021SCDC
-
Ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet
SCD · 1359022 -
{21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack
GPCK · 1359028 -
Ethinyl estradiol 0.03 MG
SCDC · 315897 -
Norethindrone acetate 1.5 MG
SCDC · 1359021 -
Ethinyl estradiol / norethindrone Oral Tablet
SCDF · 372105 -
Ethinyl estradiol / norethindrone acetate Oral Tablet
SCDFP · 2648046 -
Ethinyl estradiol / norethindrone Oral Product
SCDG · 1157354 -
Ethinyl estradiol / norethindrone Pill
SCDG · 1157355 -
Ethinyl estradiol / norethindrone acetate Oral Product
SCDGP · 2661574 -
Ethinyl estradiol / norethindrone acetate Pill
SCDGP · 2661136
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2712092 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 70700-0314-79 | 3 POUCH in 1 CARTON (70700-314-79) / 1 BLISTER PACK in 1 PO... | LUIZZA 1.5/30 | Xiromed LLC | 2025-01-29 |
Observed labelers:
Xiromed LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.3556
Range $0.3556–$0.3556
· middle 50% $0.3556–$0.3556
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.